Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma-Reference-Cited by-同舟云学术

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma

Published:2016-05-20 Issue:8 Volume:65 Page:897-907
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Albertini Mark R.^ORCID,Ranheim Erik A.,Zuleger Cindy L.,Sondel Paul M.,Hank Jacquelyn A.,Bridges Alan,Newton Michael A.,McFarland Thomas,Collins Jennifer,Clements Erin,Henry Mary Beth,Neuman Heather B.,Weber Sharon,Whalen Giles,Galili Uri

Funder

National Institutes of Health

National Cancer Institute

William S. Middleton Memorial Veterans Hospital

Clinical and Translational Science Award

Ann's Hope Foundation

Tim Eagle Memorial

Jay Van Sloan Memorial from the Steve Leuthold Family

Gretchen and Andrew Dawes Melanoma Research Fund

Agalimmune

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1846-1.pdf

Reference43 articles.

1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30. doi: 10.3322/caac.21332

2. Callahan MK, Wolchok JD (2013) At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 94:41–53. doi: 10.1189/jlb.1212631

3. McArthur GA, Ribas A (2013) Targeting oncogenic drivers and the immune system in melanoma. J Clin Oncol 31:499–506. doi: 10.1200/JCO.2012.45.5568

4. Robert C, Karaszewska B, Schachter J et al (2015) Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 372:30–39. doi: 10.1056/NEJMoa1412690

5. Larkin J, Chiarion-Sileni V, Gonzalez R et al (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373:23–34. doi: 10.1056/NEJMoa1504030

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regeneration in Mice of Injured Skin, Heart, and Spinal Cord by α-Gal Nanoparticles Recapitulates Regeneration in Amphibians;Nanomaterials;2024-04-22

2. Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides;Frontiers in Pharmacology;2024-03-13

3. Tumor treatment by pHLIP-targeted antigen delivery;Frontiers in Bioengineering and Biotechnology;2023-01-06

4. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies;Frontiers in Molecular Biosciences;2021-11-04

5. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes;Vaccine;2020-09